Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Global Cancer Treatment Drugs key players include Roche, Novartis, Celgene, Bristol-Myers Squibb, etc.
North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share over 30 percent.
In terms of product, Chemotherapy is the largest segment, with a share about 50%. And in terms of application, the largest application is Blood Cancer, followed by Breast Cancer, Prostate Cancer, Respiratory or Lung Cancer, etc.
The global Cancer Treatment Drugs market was valued at US$ 164270 million in 2020 and is expected to reach US$ 296710 million by the end of 2029, growing at a CAGR of 8.8% during 2021-2029.
This report focuses on Cancer Treatment Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cancer Treatment Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Cancer Treatment Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
1 Cancer Treatment Drugs Market Overview
1.1 Product Overview and Scope of Cancer Treatment Drugs
1.2 Cancer Treatment Drugs Segment by Type
1.2.1 Global Cancer Treatment Drugs Sales Growth Rate Comparison by Type (2021-2029)
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy (Biologic Therapy)
1.2.6 Others
1.3 Cancer Treatment Drugs Segment by Application
1.3.1 Global Cancer Treatment Drugs Sales Comparison by Application: (2021-2029)
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others
1.4 Global Cancer Treatment Drugs Market Size Estimates and Forecasts
1.4.1 Global Cancer Treatment Drugs Revenue 2016-2029
1.4.2 Global Cancer Treatment Drugs Sales 2016-2029
1.4.3 Cancer Treatment Drugs Market Size by Region: 2016 Versus 2021 Versus 2029
2 Cancer Treatment Drugs Market Competition by Manufacturers
2.1 Global Cancer Treatment Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Cancer Treatment Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Cancer Treatment Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Cancer Treatment Drugs Manufacturing Sites, Area Served, Product Type
2.5 Cancer Treatment Drugs Market Competitive Situation and Trends
2.5.1 Cancer Treatment Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cancer Treatment Drugs Players Market Share by Revenue
2.5.3 Global Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cancer Treatment Drugs Retrospective Market Scenario by Region
3.1 Global Cancer Treatment Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Cancer Treatment Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Cancer Treatment Drugs Market Facts & Figures by Country
3.3.1 North America Cancer Treatment Drugs Sales by Country
3.3.2 North America Cancer Treatment Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cancer Treatment Drugs Market Facts & Figures by Country
3.4.1 Europe Cancer Treatment Drugs Sales by Country
3.4.2 Europe Cancer Treatment Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cancer Treatment Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Cancer Treatment Drugs Sales by Region
3.5.2 Asia Pacific Cancer Treatment Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Cancer Treatment Drugs Market Facts & Figures by Country
3.6.1 Latin America Cancer Treatment Drugs Sales by Country
3.6.2 Latin America Cancer Treatment Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cancer Treatment Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Cancer Treatment Drugs Sales by Country
3.7.2 Middle East and Africa Cancer Treatment Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Cancer Treatment Drugs Historic Market Analysis by Type
4.1 Global Cancer Treatment Drugs Sales Market Share by Type (2016-2021)
4.2 Global Cancer Treatment Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Cancer Treatment Drugs Price by Type (2016-2021)
5 Global Cancer Treatment Drugs Historic Market Analysis by Application
5.1 Global Cancer Treatment Drugs Sales Market Share by Application (2016-2021)
5.2 Global Cancer Treatment Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Cancer Treatment Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Roche Cancer Treatment Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Novartis Cancer Treatment Drugs Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Celgene
6.3.1 Celgene Corporation Information
6.3.2 Celgene Description and Business Overview
6.3.3 Celgene Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Celgene Cancer Treatment Drugs Product Portfolio
6.3.5 Celgene Recent Developments/Updates
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Corporation Information
6.4.2 Bristol-Myers Squibb Description and Business Overview
6.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bristol-Myers Squibb Cancer Treatment Drugs Product Portfolio
6.4.5 Bristol-Myers Squibb Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Amgen Cancer Treatment Drugs Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Johnson & Johnson Cancer Treatment Drugs Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Cancer Treatment Drugs Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Takeda
6.8.1 Takeda Corporation Information
6.8.2 Takeda Description and Business Overview
6.8.3 Takeda Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Takeda Cancer Treatment Drugs Product Portfolio
6.8.5 Takeda Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Eli Lilly Cancer Treatment Drugs Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 AstraZeneca
6.10.1 AstraZeneca Corporation Information
6.10.2 AstraZeneca Description and Business Overview
6.10.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 AstraZeneca Cancer Treatment Drugs Product Portfolio
6.10.5 AstraZeneca Recent Developments/Updates
6.11 Astellas
6.11.1 Astellas Corporation Information
6.11.2 Astellas Cancer Treatment Drugs Description and Business Overview
6.11.3 Astellas Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Astellas Cancer Treatment Drugs Product Portfolio
6.11.5 Astellas Recent Developments/Updates
6.12 Merck & Co.
6.12.1 Merck & Co. Corporation Information
6.12.2 Merck & Co. Cancer Treatment Drugs Description and Business Overview
6.12.3 Merck & Co. Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Merck & Co. Cancer Treatment Drugs Product Portfolio
6.12.5 Merck & Co. Recent Developments/Updates
6.13 Sanofi
6.13.1 Sanofi Corporation Information
6.13.2 Sanofi Cancer Treatment Drugs Description and Business Overview
6.13.3 Sanofi Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Sanofi Cancer Treatment Drugs Product Portfolio
6.13.5 Sanofi Recent Developments/Updates
6.14 Bayer
6.14.1 Bayer Corporation Information
6.14.2 Bayer Cancer Treatment Drugs Description and Business Overview
6.14.3 Bayer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Bayer Cancer Treatment Drugs Product Portfolio
6.14.5 Bayer Recent Developments/Updates
6.15 Biogen Idec
6.15.1 Biogen Idec Corporation Information
6.15.2 Biogen Idec Cancer Treatment Drugs Description and Business Overview
6.15.3 Biogen Idec Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Biogen Idec Cancer Treatment Drugs Product Portfolio
6.15.5 Biogen Idec Recent Developments/Updates
6.16 Eisai
6.16.1 Eisai Corporation Information
6.16.2 Eisai Cancer Treatment Drugs Description and Business Overview
6.16.3 Eisai Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Eisai Cancer Treatment Drugs Product Portfolio
6.16.5 Eisai Recent Developments/Updates
6.17 Teva
6.17.1 Teva Corporation Information
6.17.2 Teva Cancer Treatment Drugs Description and Business Overview
6.17.3 Teva Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Teva Cancer Treatment Drugs Product Portfolio
6.17.5 Teva Recent Developments/Updates
6.18 Otsuka
6.18.1 Otsuka Corporation Information
6.18.2 Otsuka Cancer Treatment Drugs Description and Business Overview
6.18.3 Otsuka Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Otsuka Cancer Treatment Drugs Product Portfolio
6.18.5 Otsuka Recent Developments/Updates
6.19 Merck KGaA
6.19.1 Merck KGaA Corporation Information
6.19.2 Merck KGaA Cancer Treatment Drugs Description and Business Overview
6.19.3 Merck KGaA Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Merck KGaA Cancer Treatment Drugs Product Portfolio
6.19.5 Merck KGaA Recent Developments/Updates
6.20 Ipsen
6.20.1 Ipsen Corporation Information
6.20.2 Ipsen Cancer Treatment Drugs Description and Business Overview
6.20.3 Ipsen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Ipsen Cancer Treatment Drugs Product Portfolio
6.20.5 Ipsen Recent Developments/Updates
6.21 AbbVie
6.21.1 AbbVie Corporation Information
6.21.2 AbbVie Cancer Treatment Drugs Description and Business Overview
6.21.3 AbbVie Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.21.4 AbbVie Cancer Treatment Drugs Product Portfolio
6.21.5 AbbVie Recent Developments/Updates
6.22 Gilead Sciences
6.22.1 Gilead Sciences Corporation Information
6.22.2 Gilead Sciences Cancer Treatment Drugs Description and Business Overview
6.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Gilead Sciences Cancer Treatment Drugs Product Portfolio
6.22.5 Gilead Sciences Recent Developments/Updates
7 Cancer Treatment Drugs Manufacturing Cost Analysis
7.1 Cancer Treatment Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cancer Treatment Drugs
7.4 Cancer Treatment Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cancer Treatment Drugs Distributors List
8.3 Cancer Treatment Drugs Customers
9 Cancer Treatment Drugs Market Dynamics
9.1 Cancer Treatment Drugs Industry Trends
9.2 Cancer Treatment Drugs Growth Drivers
9.3 Cancer Treatment Drugs Market Challenges
9.4 Cancer Treatment Drugs Market Restraints
10 Global Market Forecast
10.1 Cancer Treatment Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cancer Treatment Drugs by Type (2022-2029)
10.1.2 Global Forecasted Revenue of Cancer Treatment Drugs by Type (2022-2029)
10.2 Cancer Treatment Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cancer Treatment Drugs by Application (2022-2029)
10.2.2 Global Forecasted Revenue of Cancer Treatment Drugs by Application (2022-2029)
10.3 Cancer Treatment Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cancer Treatment Drugs by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Cancer Treatment Drugs by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Cancer Treatment Drugs Sales (K Pcs) Growth Rate Comparison by Type (2021-2029)
Table 2. Global Cancer Treatment Drugs Sales (K Pcs) Comparison by Application (2021-2029)
Table 3. Global Cancer Treatment Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Cancer Treatment Drugs Covered in This Study
Table 5. Global Cancer Treatment Drugs Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Cancer Treatment Drugs Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Cancer Treatment Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Cancer Treatment Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Cancer Treatment Drugs Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Cancer Treatment Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Cancer Treatment Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Cancer Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Treatment Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Cancer Treatment Drugs Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Cancer Treatment Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Cancer Treatment Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Cancer Treatment Drugs Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Cancer Treatment Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Cancer Treatment Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Cancer Treatment Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Cancer Treatment Drugs Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Cancer Treatment Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Cancer Treatment Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Cancer Treatment Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Cancer Treatment Drugs Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Cancer Treatment Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Cancer Treatment Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Cancer Treatment Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Cancer Treatment Drugs Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Cancer Treatment Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Cancer Treatment Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Cancer Treatment Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Cancer Treatment Drugs Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Cancer Treatment Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Cancer Treatment Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Cancer Treatment Drugs Sales (K Pcs) by Type (2016-2021)
Table 39. Global Cancer Treatment Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Cancer Treatment Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Cancer Treatment Drugs Revenue Share by Type (2016-2021)
Table 42. Global Cancer Treatment Drugs Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Cancer Treatment Drugs Sales (K Pcs) by Application (2016-2021)
Table 44. Global Cancer Treatment Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Cancer Treatment Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Cancer Treatment Drugs Revenue Share by Application (2016-2021)
Table 47. Global Cancer Treatment Drugs Price (USD/Pcs) by Application (2016-2021)
Table 48. Roche Corporation Information
Table 49. Roche Description and Business Overview
Table 50. Roche Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Roche Cancer Treatment Drugs Product
Table 52. Roche Recent Developments/Updates
Table 53. Novartis Corporation Information
Table 54. Novartis Description and Business Overview
Table 55. Novartis Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Novartis Cancer Treatment Drugs Product
Table 57. Novartis Recent Developments/Updates
Table 58. Celgene Corporation Information
Table 59. Celgene Description and Business Overview
Table 60. Celgene Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Celgene Cancer Treatment Drugs Product
Table 62. Celgene Recent Developments/Updates
Table 63. Bristol-Myers Squibb Corporation Information
Table 64. Bristol-Myers Squibb Description and Business Overview
Table 65. Bristol-Myers Squibb Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Bristol-Myers Squibb Cancer Treatment Drugs Product
Table 67. Bristol-Myers Squibb Recent Developments/Updates
Table 68. Amgen Corporation Information
Table 69. Amgen Description and Business Overview
Table 70. Amgen Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Amgen Cancer Treatment Drugs Product
Table 72. Amgen Recent Developments/Updates
Table 73. Johnson & Johnson Corporation Information
Table 74. Johnson & Johnson Description and Business Overview
Table 75. Johnson & Johnson Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Johnson & Johnson Cancer Treatment Drugs Product
Table 77. Johnson & Johnson Recent Developments/Updates
Table 78. Pfizer Corporation Information
Table 79. Pfizer Description and Business Overview
Table 80. Pfizer Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Pfizer Cancer Treatment Drugs Product
Table 82. Pfizer Recent Developments/Updates
Table 83. Takeda Corporation Information
Table 84. Takeda Description and Business Overview
Table 85. Takeda Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Takeda Cancer Treatment Drugs Product
Table 87. Takeda Recent Developments/Updates
Table 88. Eli Lilly Corporation Information
Table 89. Eli Lilly Description and Business Overview
Table 90. Eli Lilly Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Eli Lilly Cancer Treatment Drugs Product
Table 92. Eli Lilly Recent Developments/Updates
Table 93. AstraZeneca Corporation Information
Table 94. AstraZeneca Description and Business Overview
Table 95. AstraZeneca Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. AstraZeneca Cancer Treatment Drugs Product
Table 97. AstraZeneca Recent Developments/Updates
Table 98. Astellas Corporation Information
Table 99. Astellas Description and Business Overview
Table 100. Astellas Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Astellas Cancer Treatment Drugs Product
Table 102. Astellas Recent Developments/Updates
Table 103. Merck & Co. Corporation Information
Table 104. Merck & Co. Description and Business Overview
Table 105. Merck & Co. Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Merck & Co. Cancer Treatment Drugs Product
Table 107. Merck & Co. Recent Developments/Updates
Table 108. Sanofi Corporation Information
Table 109. Sanofi Description and Business Overview
Table 110. Sanofi Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Sanofi Cancer Treatment Drugs Product
Table 112. Sanofi Recent Developments/Updates
Table 113. Bayer Corporation Information
Table 114. Bayer Description and Business Overview
Table 115. Bayer Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. Bayer Cancer Treatment Drugs Product
Table 117. Bayer Recent Developments/Updates
Table 118. Biogen Idec Corporation Information
Table 119. Biogen Idec Description and Business Overview
Table 120. Biogen Idec Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. Biogen Idec Cancer Treatment Drugs Product
Table 122. Biogen Idec Recent Developments/Updates
Table 123. Eisai Corporation Information
Table 124. Eisai Description and Business Overview
Table 125. Eisai Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 126. Eisai Cancer Treatment Drugs Product
Table 127. Eisai Recent Developments/Updates
Table 128. Teva Corporation Information
Table 129. Teva Description and Business Overview
Table 130. Teva Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 131. Teva Cancer Treatment Drugs Product
Table 132. Teva Recent Developments/Updates
Table 133. Otsuka Corporation Information
Table 134. Otsuka Description and Business Overview
Table 135. Otsuka Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 136. Otsuka Cancer Treatment Drugs Product
Table 137. Otsuka Recent Developments/Updates
Table 138. Merck KGaA Corporation Information
Table 139. Merck KGaA Description and Business Overview
Table 140. Merck KGaA Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 141. Merck KGaA Cancer Treatment Drugs Product
Table 142. Merck KGaA Recent Developments/Updates
Table 143. Ipsen Corporation Information
Table 144. Ipsen Description and Business Overview
Table 145. Ipsen Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 146. Ipsen Cancer Treatment Drugs Product
Table 147. Ipsen Recent Developments/Updates
Table 148. AbbVie Corporation Information
Table 149. AbbVie Description and Business Overview
Table 150. AbbVie Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 151. AbbVie Cancer Treatment Drugs Product
Table 152. AbbVie Recent Developments/Updates
Table 153. Gilead Sciences Corporation Information
Table 154. Gilead Sciences Description and Business Overview
Table 155. Gilead Sciences Cancer Treatment Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 156. Gilead Sciences Cancer Treatment Drugs Product
Table 157. Gilead Sciences Recent Developments/Updates
Table 158. Production Base and Market Concentration Rate of Raw Material
Table 159. Key Suppliers of Raw Materials
Table 160. Cancer Treatment Drugs Distributors List
Table 161. Cancer Treatment Drugs Customers List
Table 162. Cancer Treatment Drugs Market Trends
Table 163. Cancer Treatment Drugs Growth Drivers
Table 164. Cancer Treatment Drugs Market Challenges
Table 165. Cancer Treatment Drugs Market Restraints
Table 166. Global Cancer Treatment Drugs Sales Forecast by Type (2022-2029) & (K Pcs)
Table 167. Global Cancer Treatment Drugs Sales Market Share Forecast by Type (2022-2029)
Table 168. Global Cancer Treatment Drugs Revenue Forecast by Type (2022-2029) & (US$ Million)
Table 169. Global Cancer Treatment Drugs Revenue Market Share Forecast by Type (2022-2029)
Table 170. Global Cancer Treatment Drugs Sales Forecast by Application (2022-2029) & (K Pcs)
Table 171. Global Cancer Treatment Drugs Sales Market Share Forecast by Application (2022-2029)
Table 172. Global Cancer Treatment Drugs Revenue Forecast by Application (2022-2029) & (US$ Million)
Table 173. Global Cancer Treatment Drugs Revenue Market Share Forecast by Application (2022-2029)
Table 174. Global Cancer Treatment Drugs Sales Forecast by Region (2022-2029) & (K Pcs)
Table 175. Global Cancer Treatment Drugs Sales Market Share Forecast by Region (2022-2029)
Table 176. Global Cancer Treatment Drugs Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 177. Global Cancer Treatment Drugs Revenue Market Share Forecast by Region (2022-2029)
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cancer Treatment Drugs
Figure 2. Global Cancer Treatment Drugs Market Share by Type in 2020 & 2029
Figure 3. Chemotherapy Product Picture
Figure 4. Targeted Therapy Product Picture
Figure 5. Immunotherapy Product Picture
Figure 6. Hormonal Therapy (Biologic Therapy) Product Picture
Figure 7. Others Product Picture
Figure 8. Global Cancer Treatment Drugs Market Share by Application in 2020 & 2029
Figure 9. Blood Cancer
Figure 10. Breast Cancer
Figure 11. Gastrointestinal Cancer
Figure 12. Prostate Cancer
Figure 13. Respiratory or Lung Cancer
Figure 14. Others
Figure 15. Global Cancer Treatment Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 16. Global Cancer Treatment Drugs Market Size 2016-2029 (US$ Million)
Figure 17. Global Cancer Treatment Drugs Sales 2016-2029 (K Pcs)
Figure 18. Global Cancer Treatment Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 19. Cancer Treatment Drugs Sales Share by Manufacturers in 2020
Figure 20. Global Cancer Treatment Drugs Revenue Share by Manufacturers in 2020
Figure 21. The Global 5 and 10 Largest Cancer Treatment Drugs Players: Market Share by Revenue in 2020
Figure 22. Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 23. Global Cancer Treatment Drugs Sales Market Share by Region (2016-2021)
Figure 24. Global Cancer Treatment Drugs Sales Market Share by Region in 2020
Figure 25. Global Cancer Treatment Drugs Revenue Market Share by Region (2016-2021)
Figure 26. Global Cancer Treatment Drugs Revenue Market Share by Region in 2020
Figure 27. U.S. Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Canada Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Germany Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. France Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. U.K. Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Italy Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Russia Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Japan Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. South Korea Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. India Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Australia Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. China Taiwan Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Indonesia Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Thailand Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Malaysia Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. UAE Cancer Treatment Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Cancer Treatment Drugs by Type (2016-2021)
Figure 50. Sales Market Share of Cancer Treatment Drugs by Application (2016-2021)
Figure 51. Sales Market Share of Cancer Treatment Drugs by Application in 2020
Figure 52. Revenue Share of Cancer Treatment Drugs by Application (2016-2021)
Figure 53. Revenue Share of Cancer Treatment Drugs by Application in 2020
Figure 54. Manufacturing Cost Structure of Cancer Treatment Drugs
Figure 55. Manufacturing Process Analysis of Cancer Treatment Drugs
Figure 56. Cancer Treatment Drugs Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
